These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14628990)

  • 1. Reducing the risk for suicide in schizophrenia and affective disorders.
    Meltzer HY; Baldessarini RJ
    J Clin Psychiatry; 2003 Sep; 64(9):1122-9. PubMed ID: 14628990
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():41-5. PubMed ID: 9766619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine to olanzapine.
    Millson RC; Delva NJ
    Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
    [No Abstract]   [Full Text] [Related]  

  • 5. Some aspects of psychodynamic response to novel atypical antipsychotics.
    Murawiec S; Taflińska D; Tafliński T
    Harv Rev Psychiatry; 1999; 7(4):241-2. PubMed ID: 10579106
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
    Potkin SG; Alphs L; Hsu C; Krishnan KR; Anand R; Young FK; Meltzer H; Green A;
    Biol Psychiatry; 2003 Aug; 54(4):444-52. PubMed ID: 12915289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of olanzapine: an overview of pivotal clinical trials.
    Beasley CM; Tollefson GD; Tran PV
    J Clin Psychiatry; 1997; 58 Suppl 10():7-12. PubMed ID: 9265910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients.
    Di Lorenzo R; Tondelli G; Genedani S
    Int J Neuropsychopharmacol; 2001 Jun; 4(2):135-7. PubMed ID: 11466163
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine and negative and positive symptoms.
    Rifkin A
    Am J Psychiatry; 2001 May; 158(5):825. PubMed ID: 11329430
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical antipsychotics and cognition in schizophrenia.
    Sharma T
    Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comment on: "Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model" of S. Raffard, S. Bayard, D., Capdevielle, F. Garcia, J.-P. Boulenger et M.-C. Gely-Nargeot].
    Caillard V
    Encephale; 2009 Sep; 35(4):400-1. PubMed ID: 19748378
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
    Weiss EL; Longhurst JG; Bowers MB; Mazure CM
    J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of novel agents in the treatment of schizophrenia and a look to the future].
    Keks NA
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):97-101. PubMed ID: 9800201
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine and suicide.
    Ertugrul A
    Am J Psychiatry; 2002 Feb; 159(2):323; author reply 324. PubMed ID: 11823295
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response.
    Henderson DC; Nasrallah RA; Goff DC
    J Clin Psychiatry; 1998 Nov; 59(11):585-8. PubMed ID: 9862604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and suicide.
    Meltzer H
    Am J Psychiatry; 2002 Feb; 159(2):323-4. PubMed ID: 11823294
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine on trial.
    Mattes JA
    Am J Psychiatry; 1998 Jan; 155(1):153; author reply 153-5. PubMed ID: 9433359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.